Evidence map›Paper›PMID 30337371›Full record

ArticleThe Journal of biological chemistry2018

Up-regulation of the kinase gene

Mukul Godbole, Trupti Togar, Kuldeep Patel, Bhasker Dharavath, Neelima Yadav, Sharan Janjuha, Nilesh Gardi, Kanishka Tiwary, Prachi Terwadkar, Sanket Desai and 10 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cells · 2026
    Article
  4. Article
  5. Role of KDM2B epigenetic factor in regulating calcium signaling in prostate cancer cells.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Response to de Nonneville, Finetti, Mamessier, and Bertucci.Journal of the National Cancer Institute · 2022
    Article
  16. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.Journal of the National Cancer Institute · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 2 institutions in 2 countries.

Mukul GodboleFrom the Integrated Cancer Genomics Laboratory and.
Trupti TogarFrom the Integrated Cancer Genomics Laboratory and.
Kuldeep PatelFrom the Integrated Cancer Genomics Laboratory and.
Bhasker DharavathFrom the Integrated Cancer Genomics Laboratory and.
Neelima YadavFrom the Integrated Cancer Genomics Laboratory and.
Sharan JanjuhaFrom the Integrated Cancer Genomics Laboratory and.
Nilesh GardiFrom the Integrated Cancer Genomics Laboratory and.
Kanishka TiwaryFrom the Integrated Cancer Genomics Laboratory and.
Prachi TerwadkarFrom the Integrated Cancer Genomics Laboratory and.
Sanket DesaiFrom the Integrated Cancer Genomics Laboratory and.
Ratnam PrasadFrom the Integrated Cancer Genomics Laboratory and.
Hemant DhamneFrom the Integrated Cancer Genomics Laboratory and.
Kunal KarveFrom the Integrated Cancer Genomics Laboratory and.
Sameer Salunkhethe Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, Maharashtra 400094, India.
Dhananjay KawleFrom the Integrated Cancer Genomics Laboratory and.
Pratik ChandraniFrom the Integrated Cancer Genomics Laboratory and.
Shilpee Duttthe Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, Maharashtra 400094, India.
Sudeep Guptathe Department of Medical Oncology, and.ORCID 0000-0002-6742-6378
Rajendra A Badwethe Department of Surgical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Navi Mumbai, Maharashtra 410210, India and.
Amit DuttFrom the Integrated Cancer Genomics Laboratory and adutt@actrec.gov.in.ORCID 0000-0002-1119-4774
Tata Memorial Hospital · INHomi Bhabha National Institute · IN

Funding

DBT-Wellcome Trust India Alliance IA/I/11/2500278Wellcome Trust
6 · The paper itself

Abstract

Preoperative progesterone intervention has been shown to confer a survival benefit to breast cancer patients independently of their progesterone receptor (PR) status. This observation raises the question how progesterone affects the outcome of PR-negative cancer. Here, using microarray and RNA-Seq-based gene expression profiling and ChIP-Seq analyses of breast cancer cells, we observed that the serum- and glucocorticoid-regulated kinase gene (

Indexed as

Breast NeoplasmsCell Cycle ProteinsCell Line, TumorCell MovementErbB ReceptorsHumansImmediate-Early ProteinsIntracellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemNeoplasm InvasivenessN-myc Downstream-Regulated Gene 1 ProteinProgesteroneProtein Serine-Threonine KinasesReceptors, ProgesteroneSerum-Glucocorticoid Regulated KinasesTranscription Factor AP-1Cell Cycle ProteinsEGFR protein, humanErbB ReceptorsImmediate-Early ProteinsIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 ProteinProgesteroneProtein Serine-Threonine KinasesReceptors, ProgesteroneSerum-Glucocorticoid Regulated KinasesTranscription Factor AP-1breast cancercell signalingfunctional genomicsmicroRNA (miRNA)N-Myc-downstream regulated gene 1 (NDRG1)post-transcriptional regulationprogesteroneSerum- and glucocorticoid-regulated kinase 1 (SGK1)transcription factor AP-1

Identifiers

PMID30337371
PMCPMC6298595
OpenAlexW2897703617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.